Literature DB >> 7096338

The biosynthesis of rat serum albumin. In vivo studies on the formation of the disulfide bonds.

T Peters, L K Davidson.   

Abstract

In order to learn at what stage the disulfide bonds of albumin are formed during its biosynthesis, we perfused rat livers with iodoacetamide and then isolated the intracellular precursor, proalbumin, from organelles known to be in the pathway of albumin synthesis and secretion. The alkylated cysteines in proalbumin were determined as a measure of its thiol groups in vivo. Proalbumin of smooth microsomes was found to contain a single thiol, which is proposed to be the noncoupling cysteine occurring residue 34 in circulating albumin. Proalbumin in rough microsomes contained an average of two cysteines; the additional cysteine thiol was largely situated in the COOH-terminal region and disappeared rapidly after blocking albumin synthesis with cycloheximide. In nascent chains of proalbumin, about 45% of the cysteine + cystine was in the thiol form. From these findings we propose that disulfide bond formation begins while the nascent chain is still attached to the ribosome and proceeds in an NH2 to COOH direction. The disulfide bonding apparently is completed into the endoplasmic reticulum. Possible intermediates in the process such as mixed disulfide forms of proalbumin with glutathione or cystamine were not detected. We suggest that cysteine-34 does not participate in disulfide bonding because the NH2 terminus of proalbumin remains loosely bound to the membrane, attached by a hydrophobic segment of the chain at residues 21-27.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096338

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Truncated staphylococcal nuclease is compact but disordered.

Authors:  J M Flanagan; M Kataoka; D Shortle; D M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

2.  Nonuniform size distribution of nascent globin peptides, evidence for pause localization sites, and a contranslational protein-folding model.

Authors:  I A Krasheninnikov; A A Komar; I A Adzhubei
Journal:  J Protein Chem       Date:  1991-10

3.  Competition between folding and glycosylation in the endoplasmic reticulum.

Authors:  B Holst; A W Bruun; M C Kielland-Brandt; J R Winther
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

4.  Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption.

Authors:  T G Morrison; M E Peeples; L W McGinnes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Conformational changes in Newcastle disease virus fusion glycoprotein during intracellular transport.

Authors:  L W McGinnes; A Semerjian; T Morrison
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

6.  Protein disulphide-isomerase from human placenta and rat liver. Purification and immunological characterization with monoclonal antibodies.

Authors:  C S Kaetzel; C K Rao; M E Lamm
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

Review 7.  Unraveling co-translational protein folding: Concepts and methods.

Authors:  Anton A Komar
Journal:  Methods       Date:  2017-12-06       Impact factor: 3.608

8.  Cotranslational folding and calnexin binding during glycoprotein synthesis.

Authors:  W Chen; J Helenius; I Braakman; A Helenius
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

9.  In vivo formation of allosteric aspartate transcarbamoylase containing circularly permuted catalytic polypeptide chains: implications for protein folding and assembly.

Authors:  P Zhang; H K Schachman
Journal:  Protein Sci       Date:  1996-07       Impact factor: 6.725

10.  Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins.

Authors:  D J Opstelten; P de Groote; M C Horzinek; H Vennema; P J Rottier
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.